Literature DB >> 11416135

GCN5 dependence of chromatin remodeling and transcriptional activation by the GAL4 and VP16 activation domains in budding yeast.

G A Stafford1, R H Morse.   

Abstract

Chromatin-modifying enzymes such as the histone acetyltransferase GCN5 can contribute to transcriptional activation at steps subsequent to the initial binding of transcriptional activators. However, few studies have directly examined dependence of chromatin remodeling in vivo on GCN5 or other acetyltransferases, and none have examined remodeling via nucleosomal activator binding sites. In this study, we have monitored chromatin perturbation via nucleosomal binding sites in the yeast episome TALS by GAL4 derivatives in GCN5(+) and gcn5Delta yeast cells. The strong activator GAL4 shows no dependence on GCN5 for remodeling TALS chromatin, whereas GAL4-estrogen receptor-VP16 shows substantial, albeit not complete, GCN5 dependence. Mini-GAL4 derivatives having weakened interactions with TATA-binding protein and TFIIB exhibit a strong dependence on GCN5 for both transcriptional activation and TALS remodeling not seen for native GAL4. These results indicate that GCN5 can contribute to chromatin remodeling at activator binding sites and that dependence on coactivator function for a given activator can vary according to the type and strength of contacts that it makes with other factors. We also found a weaker dependence for chromatin remodeling on SPT7 than on GCN5, indicating that GCN5 can function via pathways independent of the SAGA complex. Finally, we examine dependence on GCN5 and SWI-SNF at two model promoters and find that although these two chromatin-remodeling and/or modification activities may sometimes work together, in other instances they act in complementary fashion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416135      PMCID: PMC87115          DOI: 10.1128/MCB.21.14.4568-4578.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  86 in total

Review 1.  Promoter targeting and chromatin remodeling by the SWI/SNF complex.

Authors:  C L Peterson; J L Workman
Journal:  Curr Opin Genet Dev       Date:  2000-04       Impact factor: 5.578

2.  The Gcn5 bromodomain co-ordinates nucleosome remodelling.

Authors:  P Syntichaki; I Topalidou; G Thireos
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

3.  Distribution of acetylated histones resulting from Gal4-VP16 recruitment of SAGA and NuA4 complexes.

Authors:  M Vignali; D J Steger; K E Neely; J L Workman
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 4.  Recruitment of chromatin remodeling machines.

Authors:  C L Peterson; C Logie
Journal:  J Cell Biochem       Date:  2000-05       Impact factor: 4.429

Review 5.  The many HATs of transcription coactivators.

Authors:  C E Brown; T Lechner; L Howe; J L Workman
Journal:  Trends Biochem Sci       Date:  2000-01       Impact factor: 13.807

Review 6.  Transcriptional activation by recruitment.

Authors:  M Ptashne; A Gann
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

7.  Chromatin remodelling at the PHO8 promoter requires SWI-SNF and SAGA at a step subsequent to activator binding.

Authors:  P D Gregory; A Schmid; M Zavari; M Münsterkötter; W Hörz
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

8.  Artificially recruited TATA-binding protein fails to remodel chromatin and does not activate three promoters that require chromatin remodeling.

Authors:  M P Ryan; G A Stafford; L Yu; R H Morse
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Global role for chromatin remodeling enzymes in mitotic gene expression.

Authors:  J E Krebs; C J Fry; M L Samuels; C L Peterson
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

10.  Two distinct nucleosome alterations characterize chromatin remodeling at the Saccharomyces cerevisiae ADH2 promoter.

Authors:  E Di Mauro; S G Kendrew; M Caserta
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

View more
  8 in total

1.  Promoter occupancy is a major determinant of chromatin remodeling enzyme requirements.

Authors:  Archana Dhasarathy; Michael P Kladde
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength.

Authors:  George Koutroubas; Menie Merika; Dimitris Thanos
Journal:  Mol Cell Biol       Date:  2007-11-19       Impact factor: 4.272

3.  A nucleosome positioned by alpha2/Mcm1 prevents Hap1 activator binding in vivo.

Authors:  Nobuyuki Morohashi; Kumiko Nakajima; Daichi Kurihara; Yukio Mukai; Aaron P Mitchell; Mitsuhiro Shimizu
Journal:  Biochem Biophys Res Commun       Date:  2007-10-16       Impact factor: 3.575

4.  Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitro.

Authors:  Sebla B Kutluay; Sarah L DeVos; Jennifer E Klomp; Steven J Triezenberg
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

5.  Regulation of histone deposition on the herpes simplex virus type 1 genome during lytic infection.

Authors:  Sebla B Kutluay; Steven J Triezenberg
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

6.  A role for gcn5-mediated global histone acetylation in transcriptional regulation.

Authors:  Rachel Maria Imoberdorf; Irini Topalidou; Michel Strubin
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  GAL4 induces transcriptionally active puff in the absence of dSAGA- and ATAC-specific chromatin acetylation in the Drosophila melanogaster polytene chromosome.

Authors:  Anita Ciurciu; István Tombácz; Cristina Popescu; Imre Boros
Journal:  Chromosoma       Date:  2009-05-02       Impact factor: 4.316

8.  Quantitative imaging of chromatin decompaction in living cells.

Authors:  Elisa Dultz; Roberta Mancini; Guido Polles; Pascal Vallotton; Frank Alber; Karsten Weis
Journal:  Mol Biol Cell       Date:  2018-05-17       Impact factor: 4.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.